Unique ID issued by UMIN | UMIN000012184 |
---|---|
Receipt number | R000014207 |
Scientific Title | A phase II study of concurrent chemoradiotherapy with 5-fluorouracil and mitomycin-C for squamous cell carcinoma of the anal canal |
Date of disclosure of the study information | 2013/11/01 |
Last modified on | 2024/02/28 10:18:31 |
A phase II study of concurrent chemoradiotherapy with 5-fluorouracil and mitomycin-C for squamous cell carcinoma of the anal canal
A phase II study of concurrent chemoradiotherapy with 5-fluorouracil and mitomycin-C for squamous cell carcinoma of the anal canal
A phase II study of concurrent chemoradiotherapy with 5-fluorouracil and mitomycin-C for squamous cell carcinoma of the anal canal
A phase II study of concurrent chemoradiotherapy with 5-fluorouracil and mitomycin-C for squamous cell carcinoma of the anal canal
Japan |
squamous cell carcinoma of the anal canal
Radiology |
Malignancy
NO
To evaluate the efficacy and the safety of concurrent chemoradiotherapy with 5-FU and Mitomycin C for patients with squamous cell carcinoma of anal canal.
Efficacy
Phase II
2-year disease-free survival
Interventional
Single arm
Non-randomized
Open -no one is blinded
Historical
1
Treatment
Medicine | Device,equipment |
Chemoradiotherapy
20 | years-old | <= |
80 | years-old | >= |
Male and Female
1) Histologically diagnosed squamous cell carcinoma of anal canal
2) TNM(7th Version) T1-4N0-3M0
3) ECOG PS 0-1
4) Age between 20 and 80
5) Fit for chemotherapy
6) No prior treatment for anal canal cancer
7) No prior history of pelvic radiation therapy
8) Written informed consent
1) Other active cancer
2) Severe active co-morbidity such as severe heart disease, uncontrolled DM, and severe infection
3) Women who are or would be pregnant or who are lactating
4) Anti-HIV Ab positive
5) HBs Ag positive
6) Patient who the physician in charge judged unsuitable
40
1st name | Katsuyuki |
Middle name | |
Last name | Karasawa |
Tokyo Metropolitan Komagome Hospital
Department of Radiology
113-0021
3-18-22, Honkomagome, Bunkyo-ku, Tokyo
03-3823-2101
karasawa@cick.jp
1st name | Katsuyuki |
Middle name | |
Last name | Karasawa |
Tokyo Metropolitan Komagome Hospital
Department of Radiology
113-0021
3-18-22, Honkomagome, Bunkyo-ku, Tokyo
03-3823-2101
karasawa@cick.jp
Japanese Radiation Oncology Study Group
Japanese Radiation Oncology Study Group
Self funding
Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital
3-18-22, Honkomagome, Bunkyo-ku, Tokyo
03-3823-2101
rinri@cick.jp
YES
jRCTs041180053
Japan Registry of Clinical Trials
2013 | Year | 11 | Month | 01 | Day |
Unpublished
Completed
2013 | Year | 09 | Month | 19 | Day |
2013 | Year | 09 | Month | 19 | Day |
2013 | Year | 11 | Month | 01 | Day |
2021 | Year | 12 | Month | 16 | Day |
Since this study was classified as a specified clinical trial, we continue to disclose information in the jRCT.
2013 | Year | 10 | Month | 31 | Day |
2024 | Year | 02 | Month | 28 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000014207
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |